It provides an opportunity to discover the world of psychedelic medicine, and is attended by some of the. Please speak to a health care provider if you have any medical concerns and always exercise caution and care. Weve partnered with MAPS to take over MAPS Backlot for the night! Microdoses leaders also partnered with Third Waves team, offering our friends and followers a verified Wonderland discount code to ease the financial investment. But perhaps the most meaningful value of the conference happens over dinner and drinks. Think youd be a fit to speak at Wonderland? Not consenting or withdrawing consent, may adversely affect certain features and functions. from Tulane University School of Medicine Dr. Gukasyan completed her internship a, Yitz Klein is the founder of Trippy.vc, a psychedelic therapy impact investment fund Trippy.vc is focused on operating its vertically owned research and retreat healing pods in Jamaica, Israel, NY , LnSan Moonwalker has been an oracle, healer, spiritual teacher, and environmental guardian for more than 45 years. He has been with the FDA and USPHS for 13 years and current, Mr. Moreau is the CEO of Algernon Pharmaceuticals Inc. and a member of the companys board of directors. Nov 3 5 | Miami, USA Wonderland will be the one psychedelics conference you won't want to miss out on. Every day when the exhibition floor shuts down, attendees can enjoy a two-hour cocktail party sparking engaging conversations with unexpected connections. Algernon Pharmaceuticals Secures Lead Sponsorship of 2022 Wonderland Psychedelic Conference in Miami. Dr. Prash Puspanathan is a medical doctor and former Neuropsychiatry Fellow at The Alfred Hospital in Melbourne, one of Australias leading advocates for accessible psychedelic-assisted psychotherapy. Algernon Pharmaceuticals Secures Lead Sponsorship of 2022 Wonderland Psychedelic Conference in Miami. The awards ceremony will take place on. Algernon is a drug re-purposing company that investigates safe, already approved drugs, including naturally occurring compounds, for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. We are delighted to be supporting Microdose in this industry-leading event and to be a part of their mission to increase visibility for this growing and important sector, said David Dinkin, Investment Banking, H.C. Wainwright & Co., LLC.